Clearwater International acted as sole financial adviser to palero capital on the sale of 100% of the share capital of Lausitzer Analytik GmbH (LAG) to SYNLAB Group (SYNLAB), a portfolio company of Cinven.
LAG, established in 1993, headquartered in Spremberg (Germany), is a laboratory testing specialist in fuel, oil and environmental testing with a leading position in Southern Brandenburg and Northern Saxony regions. The company provides a wide range of environmental testing services including water, soil and air analysis with in-depth expertise in fuel, coal and oil analytics for clients in the mining, industrial and energy producing sectors.
SYNLAB is a leading laboratory service provider in Germany and Europe with 13,000 employees and revenues of ~ €1.5 bn. SYNLAB offers a full range of medical laboratory services for practicing doctors, clinics and the pharmaceutical industry in more than 30 countries across four continents. In addition, the group operates laboratories for veterinary and environmental laboratory analysis.
The Clearwater International team was led by Managing Partner Markus Otto, Associate Director Gunther Haberkamm and supported by Daniel Stratenhoff and Anton Ulrich.
This transaction is the latest deal completed by Clearwater International’s healthcare team. Clearwater has built on its leading position in healthcare, having completed 68 transactions in this sector with €2.8 bn transaction volume.